<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        1-5138-18
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2018
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        MEXIA 10 mg Film-coated Tablet
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        MEMANTINE HYDROCHLORIDE
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        10
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Film-coated tablet
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        28
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Blister
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        24
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        28.727
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="NOBELFARMA ILAC SAN . VE TIC. A.S." />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            NOBELFARMA ILAC SAN . VE TIC. A.S.
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 548]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            AL HOBAIL MEDICAL OFFICE COMPANY LTD.
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            NOBELFARMA ILAC SAN . VE TIC. A.S.
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        N06DX01
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">Pharmacotherapeutic group: </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">MEXIA belongs to a group of medicines known as anti-dementia medicines. </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">Memory loss in Alzheimer&#39;s disease is due to a disturbance of message signals in the brain. </font><font style="vertical-align: inherit;">The brain contains so-called N-methyl-D-aspartate (NMDA) -receptors that are involved in transmitting nerve signals important in learning and memory. </font><font style="vertical-align: inherit;">MEXIA belongs to a group of medicines called NMDA-receptor antagonists. </font><font style="vertical-align: inherit;">MEXIA acts on these NMDA-receptors improving the transmission of nerve signals and the memory. </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">- Therapeutic indications: </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">MEXIA is used for the treatment of patients with moderate to severe Alzheimer&#39;s disease</font></font></p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">a. </font><font style="vertical-align: inherit;">Do not take MEXIA: </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">- if you are allergic to memantine hydrochloride or any of the other ingredients of MEXIA.</font></font></p><p><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">b. </font><font style="vertical-align: inherit;">Take special care with MEXIA: </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">- if you have a history of epileptic seizures. </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">- if you have recently experienced a myocardial infarction (heart attack), or if you are suffering from congestive heart failure or from an uncontrolled hypertension (high blood pressure). </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">In these situations the treatment should be carefully supervised, and the clinical benefit of MEXIA reassessed by your doctor on a regular basis. </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">If you suffer from renal impairment (kidney problems), your doctor should closely monitor your kidney function and if necessary adapt the memantine doses accordingly.</font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">The use of medicinal products called amantadine (for the treatment of Parkinson&#39;s disease), ketamine (a substance generally used as an anesthetic), dextromethorphan (generally used to treat cough) and other NMDA-antagonists at the same time should be avoided. </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">MEXIA is not recommended for children and adolescents under the age of 18 years. </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">c. </font><font style="vertical-align: inherit;">Taking other medicines, herbal or dietary supplements </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">Tell your doctor or pharmacist if you are taking, have recently taken or maight take any other medicines, including medicines obtained without prescription. </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">In particular, MEXIA may change the effects of the following medicines and their dose may need to be adjusted by your doctor: </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">- amantadine, ketamine, dextromethorphan </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">- dantrolene, baclofen</font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">- cimetidine, ranitidine, procainamide, quinidine, quinine, nicotine </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">- hydrochlorothiazide (or any combination with hydrochlorothiazide) </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">- anticholinergics (generally used to treat disorders or intestinal cramps) </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">- anticonvulsants (substances used to prevent and relieve seizures) </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">- barbiturates (substances used </font><font style="vertical-align: inherit;">to prevent and relieve seizures) </font><font style="vertical-align: inherit;">- barbiturates (substances used </font><font style="vertical-align: inherit;">to prevent and relieve seizures) </font><font style="vertical-align: inherit;">used to prevent and relieve seizures) - barbiturates (substances used to prevent and relieve seizures) </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">- dopaminergic agonists (substances such as L-dopa, bromocriptine) </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">- neuroleptics (substances used in the treatment of mental disorders) </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">- oral anticoagulants </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">If you go into, let your doctor know that you are taking MEXIA. </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">d. </font><font style="vertical-align: inherit;">Taking MEXIA with food and drink</font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">You should inform your doctor if you have recently changed or intend to change your diet substantially (eg from normal diet to strict vegetarian diet) or if you are suffering from states of renal tubulary acidosis (RTA, an excess of acid-forming substances in the Blood due to renal dysfunction (poor kidney function)) or severe infections of the urinary tract (structure that carries urine), as your doctor may need to adjust the dose of your medicine.</font></font></p><p><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">e. </font><font style="vertical-align: inherit;">Pregnancy and breast-feeding </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">The use of memantine in pregnant women is not recommended. </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">Women taking MEXIA should not breast-feed. </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">Ask your doctor or pharmacist for advice before taking any medicine. </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">f. </font><font style="vertical-align: inherit;">Driving and using machines </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">Your doctor will tell you whether your illness allows you to drive and to use machines safely. </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">Also, MEXIA may change your reactivity, making driving or operating machinery inappropriate. </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">g. </font><font style="vertical-align: inherit;">Important information about some of the ingredients of MEXIA </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">MEXIA contains lactose monohydrate. </font><font style="vertical-align: inherit;">If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicinal product.</font></font></p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">Always take MEXIA exactly as your doctor or has told you. </font><font style="vertical-align: inherit;">You should check with your doctor or pharmacist if you are not sure. </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">&bull; Dosage </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">The recommended dose of MEXIA for adults and elderly patients is 20 mg once a day. </font><font style="vertical-align: inherit;">In order to reduce the risk of side effects this dose is achieved gradually by the following daily treatment scheme: </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">week 1 </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">half a 10 mg tablet </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">week 2 </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">one 10 mg tablet </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">week 3 </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">one and a half 10 mg tablet </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">week 4 and beyond </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">two 10 mg tablets once a day</font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">The usual starting dose is half a tablet once a day (1 x 5 mg) for the first week. </font><font style="vertical-align: inherit;">This is increased to one tablet once a day (1 x 10 mg) in the second week and to 1 and a half tablet once a day in the third week. </font><font style="vertical-align: inherit;">From the fourth week on, the usual dose is 2 tablets once a day (1 x 20 mg). </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">Dosage in patients with impaired kidney function: </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">If you have impaired kidney function, your doctor will decide upon a dose that suits your condition. </font><font style="vertical-align: inherit;">In this case, monitoring of your kidney function should be performed by your doctor at specified intervals.</font></font></p><p><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">&bull; Method of administration </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">MEXIA should be administered orally once a day. </font><font style="vertical-align: inherit;">To benefit from your medicine you should take it regularly every day at the same time of the day. </font><font style="vertical-align: inherit;">The tablets should be swallowed with some water. </font><font style="vertical-align: inherit;">The tablets can be taken with or without food. </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">&bull; Duration of treatment </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">Continue to take MEXIA as long as it is of benefit to you. </font><font style="vertical-align: inherit;">Your doctor should assess your treatment on a regular basis. </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">a. </font><font style="vertical-align: inherit;">If you use more MEXIA than you should </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">In general, taking too much MEXIA should not result in any harm to you. </font><font style="vertical-align: inherit;">You may experience increased symptoms as described in section 4. &ldquo;Possible side effects&rdquo;. </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">If you take a large overdose of MEXIA, contact your doctor or get medical advice, as you may need medical attention.</font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">b. </font><font style="vertical-align: inherit;">If you forget to use MEXIA </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">If you find you have forgotten to take your dose of MEXIA, wait and take your next dose at the usual time. </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">Do not take a double dose to make up for a forgotten dose. </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">If you have any further questions on the use of this medicine, ask your doctor or pharmacist.</font></font></p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">Like all medicines, this medicine can cause side effects, although not everybody gets them. </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">In general, the observed side effects are mild to moderate. </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">Common (affects 1 to 10 users in 100): </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">- Headache, sleepiness, constipation, dizziness, shortness of breath, high blood pressure and drug hypersensitivity </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">Uncommon (affects 1 to 10 users in 1,000): </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">- Tiredness, fungal infections, confusion, hallucinations , vomiting, abnormal gait, heart failure and venous blood clotting (thrombosis / thromboembolism) </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">Very rare (affects less than 1 user in 10,000): </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">- Seizures </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">Not known (frequency cannot be estimated from the available data): </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">- Inflammation of the pancreas and psychotic reactions</font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">Alzheimer&#39;s disease has been associated with depression, suicidal ideation and suicide. </font><font style="vertical-align: inherit;">These events have been reported in patients treated with memantine</font></font></p><p><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist</font></font></p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">Keep out of the reach and sight of children. </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">Do not store above 25&ordm;C, store in the original pack. </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">Do not use this medicine after the expiry date which is stated on the carton and the blister after EXP. </font><font style="vertical-align: inherit;">The expiry date refers to the last day of that month. </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">Medicines should not be disposed of via wastewater or household waste. </font><font style="vertical-align: inherit;">Ask your pharmacist how to dipose of medicines no longer required. </font><font style="vertical-align: inherit;">These measures will help protect the environment</font></font></p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">The active substance is: memantine hydrochloride. </font><font style="vertical-align: inherit;">Each film-coated tablet contains 10 mg memantine hydrochloride. </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">- The other ingredients are: </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">Tablet core: </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">Microcrystalline cellulose PH 302 (Avicel PH 302) </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">Lactose DC (Ludipress LCE: Lactose monohydrate + Povidone 30) </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">Colloidal silica anhydrous (Aerosil 200) </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">Talc </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">Magnesium stearate </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">Tablet coat: </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">Film coating material no: 8) Opadry Y-1 7000 White): </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">HPMC 2910 / Hypromellose 5 CP (E464) </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">Titanium Dioxide (E171) </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">Macrogol / PEG 400 (E1521)</font></font></p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                MEXIA is presented as White to off white colored, oblong shaped narrowing in the middle, biconvex, notched on both faces, film coated tablets
MEXIA film-coated tablets are available as:
28 film-coated tablets / 2 blisters / 1 box (14 film-coated tablets / 1 blister)
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">NOBEL İLA&Ccedil; SAN. </font><font style="vertical-align: inherit;">VE TİC. </font><font style="vertical-align: inherit;">A.Ş. </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">İnkılap Mahallesi Ak&ccedil;akoca Sokak No: 10 </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">34768 &Uuml;mraniye / İSTANBUL / T&Uuml;RKİYE </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">Tel: +90 (216) 633 60 00 </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">Fax: +90 (216) 633 60 01</font></font></p><p><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">Manufacturer </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">NOBELFARMA İLA&Ccedil; SANAYİİ VE TİCARET A.Ş. </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">Sancaklar, 81100 </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">D&uuml;zce / TURKEY </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">Phone No: + 90.380.524 00 50 </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">Fax No: + 90.380.524 00 53</font></font></p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                This leaflet was last approved in (10/2015); (version 01 )
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">Pharmacotherapeutic group: Mexia belongs to a group of medicines known as anti-presbyopia medicines.</font></font></p><p><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">Memory loss in Alzheimer&#39;s disease is due to a disorder that signals messages in the brain. </font><font style="vertical-align: inherit;">The brain contains </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">so-called N-methyl-d-aspartate receptors that are involved in transmitting nerve signals important for learning and memory. </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">MEXIA belongs to a group of medicines called N-methyl-d-aspartate receptor antagonists. </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">MEXIA works on N-methyl-d-aspartate receptors, which improves nerve signal transmission and memory. </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">Indication: </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">MIXIA is used to treat patients with moderate to severe Alzheimer&#39;s disease.</font></font></p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">A- Do not take Mexia: </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">if you are allergic to hydrochloride memantine or any of the other ingredients of Mexia. </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">B - Exercise caution while using Mixa: </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">- If you have a history of illness indicating epileptic seizures. </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">- If you have recently had a myocardial infarction (heart attack) or if you suffer from congestive heart failure or </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">uncontrolled high blood pressure. </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">In the event of such cases, treatment should be well supervised, and the clinical benefits of Mexia should be reassessed </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">by the attending physician regularly. </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">If you have impaired kidney function (kidney problems), the doctor will closely monitor your kidney function and </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">, if necessary, adjust the doses of menthene accordingly.</font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">Medicinal products called amtadine (to treat Parkinson&#39;s disease) and ketamine should be avoided. </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">It is a substance that is generally used as an anesthetic) and dextromethorphan (which is generally used to treat </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">coughs) and other anti-N-methyl-d-aspartate drugs at the same time. </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">Mixa is not recommended for children and adolescents under the age of 18</font></font></p><p><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">C- Taking other medicines, herbal medicines or nutritional supplements: </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">Tell your doctor or pharmacist if you are taking or have recently taken, or you may use other medicines, including medicines </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">bought without a prescription. </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">Mixa in particular may alter the effect of the following medicines, and doses may need to be adjusted by your attending physician </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">: </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">- amantadine, ketamine and dextro methorphan. </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">Dantrolene and baclofen. </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">Cimetidine, Renitidine, Procainamide, Quinidine, Quinine and Nicotine. </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">Hydroclorothiazide (or any mixture with hydrochlorothiazide). </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">Neuroleptics (substances used to treat mental disorders). </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">Oral anticoagulants. </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">Do not use Vagan PE.</font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">Anticonvulsants (substances used to prevent and relieve seizures). </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">Barbiturate (substances commonly used to induce sleep). </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">Dopa, bromocriptine, dopamine agonists). </font><font style="vertical-align: inherit;">- L) - anti-colinergics substances such as </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">If you sleep in a hospital, inform the attending physician that you are using Mixa. </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">D- Using Mixa with food and drink: </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">You should inform your doctor if you have recently changed or intend to substantially change your diet (for example: a </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">normal diet to a strict vegetarian diet) or if you suffer from cases of increased tubular renal acidification (these are: The condition </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">is an increase in the acid-forming substances in the blood due to impaired kidney function (impaired kidney function) or</font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">Severe inflammatory state of the urinary tract (&ldquo;urine excretory tissues&rdquo;), as the doctor may adjust the dose of your medicine. </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">E- Pregnancy and lactation</font></font></p><p><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">Memanine is not recommended for use in pregnant women. </font><font style="vertical-align: inherit;">The mother using Mixa should not breast-feed. </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">Ask a doctor or pharmacist for advice before using any medication. </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">F - Driving and operating machines: </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">The doctor will inform you if your illness allows you to drive cars and operate the machinery safely. </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">Mixa may change your reactions, ie driving a car or operating machinery may be inappropriate. </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">G- Important information about some of the ingredients of Mixa: </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">Mixa contains lactose monohydrate. </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">If you have been told by your doctor that you are intolerant to some sugars, contact your doctor before using any medicinal product.</font></font></p><p>&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">Always use mexia in the same way your doctor tells you to. </font><font style="vertical-align: inherit;">You should check with the doctor or pharmacist if in </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">doubt. </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">Dosage: </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">The recommended dose of Mixa for adults and the elderly is 20 mg once daily. </font><font style="vertical-align: inherit;">To reduce the risk of side effects </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">, this dose is gradually reached through the following daily regimen:</font></font></p><p><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">First week </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">class</font></font></p><table border="1" cellspacing="1" cellpadding="1" style="width:416px"><tbody><tr><td style="width:151px"><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">First week</font></font></td><td style="width:262px"><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">Half of the 10 mg tablet</font></font></td></tr><tr><td style="width:151px"><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">second week</font></font></td><td style="width:262px"><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">One 10 mg tablet</font></font></td></tr><tr><td style="width:151px"><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">One 10 mg tablet</font></font></td><td style="width:262px"><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">One and a half 10 mg tablet</font></font></td></tr><tr><td style="width:151px"><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">The fourth week and beyond</font></font></td><td style="width:262px"><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">2 tablets of 10 mg once daily</font></font></td></tr></tbody></table><p><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">The usual starting dose is one-half of one tablet daily (5x1 mg) for the first week and then increased to one tablet.</font></font></p><p><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">Daily (10x1 mg) in the second week and then to one and a half tablet once a day in the third week.</font></font></p><p><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">The fourth week onwards, the usual dose is 2 tablets once daily (20 x 1 mg).</font></font></p><p><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">Dosage for patients with impaired renal function: </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">If you have impaired renal function, your doctor will determine the dose that is most appropriate for your condition. </font><font style="vertical-align: inherit;">In this case, the </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">renal function should be monitored by the physician at specified intervals. </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">Method of administration: </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">MIX should be given orally once a day. </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">To benefit from this medicine, you must take it regularly every day at the same time. </font><font style="vertical-align: inherit;">The tablets should be swallowed with a little water. </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">The tablets can be taken with or without food. </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">Duration of treatment: </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">Continue to use Mixa for as long as you benefit from it. </font><font style="vertical-align: inherit;">The doctor should regularly evaluate your response to treatment. </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">A- If you take more Mixa than you should, you should do the following:</font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">In general, taking more Mixa will not cause you any harm. </font><font style="vertical-align: inherit;">You may have increased symptoms, such as those below </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">We show them in Section 4 &quot;Possible Side Effects.&quot; </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">If you have taken a large overdose of Mexia, contact your doctor for medical advice as you may need </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">medical attention. </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">B- If you forget to take Mexia: </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">If you forget to take your usual dose of Mixa, wait, and take your next dose at the usual time. </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">Do not take a double dose to make up for a forgotten dose. </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">If you have any further questions regarding the use of this medicine, consult your doctor or pharmacist.</font></font></p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">Like all medicines, this medicine can cause side effects, although they may not occur in all patients. </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">In general, the observed side effects range from mild to moderate. </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">Common effects (affect 1 to 10 patients out of 100 patients): </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">headache, a tendency to sleep, constipation, dizziness, gasping, high blood pressure and sensitivity to the drug. </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">Uncommon effects (affect 1 to 10 patients out of 1,000): </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">fatigue, fungal infections, confusion, hallucinations and vomiting, abdominal pain, heart failure and venous blood clotting </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">(venous thrombosis / pulmonary thrombosis). </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">Very rare effects (affect less than 1 in 10,000 patients): </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">Seizures. </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">Unknown effects: </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">(frequency cannot be estimated from the available data).</font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">Pancreatitis, psychotic reactions. </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">Alzheimer&#39;s disease is associated with depression, suicidal thoughts, and suicide. </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">Reports of these cases have been received with patients being treated with memantine. </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">In the event that one of these side effects develops into a more serious condition or if you notice a side effect not listed in this </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">leaflet, tell your doctor or pharmacist.</font></font></p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">Keep all medicines out of the reach and sight of children. </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">Do not store it at a temperature higher than 30 &deg; C, and it should be stored in the original package</font></font></p><p><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">Do not use this medicine after the expiry date which is stated on the carton and blister. </font><font style="vertical-align: inherit;">The expiry date refers to the last day of </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">that month. </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">Medicines should not be disposed of via sewage or household waste. </font><font style="vertical-align: inherit;">Ask your pharmacist to </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">dispose of medicines that are no longer needed. </font><font style="vertical-align: inherit;">These measures will help protect the environment.</font></font></p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">A- What MEXIA contains: </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">The active ingredient is: memantine hydrochloride. </font><font style="vertical-align: inherit;">Each glue contains 10 mg of memantine hydrochloride. </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">Components are On: </font><font style="vertical-align: inherit;">other: </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">. </font><font style="vertical-align: inherit;">Cellulose micro Albllo a rate Bhd 302 (Ov&iacute;s l Bhd 302 </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">). Lactose DC (for the CIA: unilateral Head of rate Lactose + povidone 30 </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">). Silica Algr and vessels of anhydrous (A ros l 200 </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">talc. </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">Six Magnesium cartridge. Tablet </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">cover:</font></font></p><p><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">Band-wrapping material number: 8 (Ubardi Y-1 7000 white</font></font></p><p><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">2910 / hyper bromelose</font></font></p><p><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">Hyperpromyllose 5 ci (E464)</font></font></p><p><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">Titanium dioxide (E171)</font></font></p><p><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">Macrogol / polyethylene glycol 400 (E1521)</font></font></p><p>&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">B-Shape and contents of the package: </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">Mixa comes in the form of a matte white disc, long in shape, narrow in the middle, concave on both sides, notches </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">/ pits on both sides and coated.</font></font></p><p><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">The Mixa tablets are available in the form of: </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">28 coated tablets / 2 blisters / 1 box (4 tablets / 1 strip).</font></font></p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">The Marketing </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">Authorization Holder Nobel Elak San V TIC AS Analyst </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">Coup Exakuka Sokak No. </font><font style="vertical-align: inherit;">10 </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">34768 Amman / Istanbul / Turkey </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">+90 (216) 633 60 Tel: 00 </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">+90 (216) 633 60 Fax: 01 </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">Manufacturer: </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">Nobel Pharma Elac Makers in Tikarit AS </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">Sancaklar, 81100 </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">DOSZ / Turkey </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">+90 380 524 00 number Telephone: 50 </font></font><br /><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">+90 380 524 00 Fax: 53</font></font></p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            د. اعتمدت هذه النشرة في (اكتوبر / 2015 ) ( رقم الاصدار 01 (
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                MEXIA 10 mg film-coated tablets
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Each film-coated tablet contains 10 mg of memantine hydrochloride.
Excipients:
Lactose monohydrate…………………..82.83 mg
For a full list of excipients, see section 6.1.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Film-coated tablets.
White to off white colored, oblong shaped narrowing in the middle, biconvex, notched on both faces, film coated tablets
The tablet can be divided into equal halves.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Treatment of patients with moderate to severe Alzheimer&rsquo;s disease.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Treatment should be initiated and supervised by a physician experienced in the diagnosis and treatment of Alzheimer&rsquo;s dementia. Therapy should only be started if a caregiver is available who will regularly monitor the intake of the medicinal product by the patient. Diagnosis should be made according to current guidelines. The tolerance and dosing of memantine should be reassessed on a regular basis, preferably within three months after start of treatment. Thereafter, the clinical benefit of memantine and the patient&#39;s tolerance of treatment should be reassessed on a regular basis according to current clinical guidelines. Maintenance treatment can be continued for as long as a therapeutic benefit is favourable and the patient tolerates treatment with memantine. Discontinuation of memantine should be considered when evidence of a therapeutic effect is no longer present or if the patient does not tolerate treatment.</p><p>MEXIA should be administered once a day and should be taken at the same time every day. The film-coated tablets can be taken with or without food.<br />Posology:<br />Adults:<br />Dose titration<br />The maximum daily dose is 20 mg per day. In order to reduce the risk of undesirable effects, the maintenance dose is achieved by upward titration of 5 mg per week over the first 3 weeks as follows:<br />Week 1 (day 1-7):<br />The patient should take half a 10 mg film-coated tablet (5 mg) per day for 7 days.<br />Week 2 (day 8-14):<br />The patient should take one 10 mg film-coated tablet (10 mg) per day for 7 days.<br />Week 3 (day 15-21):<br />The patient should take one and a half 10 mg film-coated tablet (15 mg) per day for 7 days.<br />From Week 4 on:<br />The patient should take two 10 mg film-coated tablets (20 mg) per day.<br />Maintenance dose<br />The recommended maintenance dose is 20 mg per day.<br />Special populations<br />Elderly<br />On the basis of the clinical studies, the recommended dose for patients over the age of 65 years is 20 mg per day (two 10 mg film-coated tablets once a day) as described above.<br />Children and adolescents<br />MEXIA is not recommended for use in children below 18 years due to a lack of data on safety and efficacy.<br />Renal impairment<br />In patients with mildly impaired renal function (creatinine clearance 50&ndash;80 ml/min) no dose adjustment is required. In patients with moderate renal impairment (creatinine clearance 30-49 ml/min) daily dose should be 10 mg per day. If tolerated well after at least 7 days of treatment, the dose could be increased up to 20 mg/day according to standard titration scheme. In patients with severe renal impairment (creatinine clearance 5&ndash;29 ml/min) daily dose should be 10 mg per day.<br />Hepatic impairment<br />In patients with mild or moderate hepatic impaired function (Child-Pugh A and Child-Pugh B), no dose adjustment is needed. No data on the use of memantine in patients with severe hepatic impairment are available. Administration of MEXIA is not recommended in patients with severe hepatic impairment.</p><p>Method of administration<br />For oral use.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p style="text-indent:50px">Caution is recommended in patients with epilepsy, former history of convulsions or patients with predisposing factors for epilepsy.<br />Concomitant use of N-methyl-D-aspartate (NMDA)-antagonists such as amantadine, ketamine or dextromethorphan should be avoided. These compounds act at the same receptor system as memantine, and therefore adverse reactions (mainly central nervous system (CNS)-related) may be more frequent or more pronounced (see also section 4.5).<br />Some factors that may raise urine pH (see section 5.2 &ldquo;Elimination&rdquo;) may necessitate careful monitoring of the patient. These factors include drastic changes in diet, e.g. from a carnivore to a vegetarian diet, or a massive ingestion of alkalising gastric buffers. Also, urine pH may be elevated by states of renal tubulary acidosis (RTA) or severe infections of the urinary tract with Proteus bacteria.<br />In most clinical trials, patients with recent myocardial infarction, uncompensated congestive heart failure (NYHA III-IV), or uncontrolled hypertension were excluded. As a consequence, only limited data are available and patients with these conditions should be closely supervised.<br />MEXIA contains lactose monohydrate. Patients with rare hereditary problems of galactose intolerance, the Lapp lactase deficiency or glucose-galactose malabsorption should not take this medicine.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Due to the pharmacological effects and the mechanism of action of memantine the following interactions may occur:<br />- The mode of action suggests that the effects of L-dopa, dopaminergic agonists, and anticholinergics may be enhanced by concomitant treatment with NMDA-antagonists such as memantine. The effects of barbiturates and neuroleptics may be reduced. Concomitant administration of memantine with the antispasmodic agents, dantrolene or baclofen, can modify their effects and a dose adjustment may be necessary.<br />- Concomitant use of memantine and amantadine should be avoided, owing to the risk of pharmacotoxic psychosis. Both compounds are chemically related NMDA-antagonists. The same may be true for ketamine and dextromethorphan (see also section 4.4). There is one published case report on a possible risk also for the combination of memantine and phenytoin.<br />- Other active substances such as cimetidine, ranitidine, procainamide, quinidine, quinine and nicotine that use the same renal cationic transport system as amantadine&nbsp;may also possibly interact with memantine leading to a potential risk of increased plasma levels.<br />- There may be a possibility of reduced serum level of hydrochlorothiazide (HCT) when memantine is co-administered with HCT or any combination with HCT.<br />- In post-marketing experience isolated cases with international normalized ratio (INR) increases have been reported in patients concomitantly treated with warfarin. Although no causal relationship has been established, close monitoring of prothrombin time or INR is advisable for patients concomitantly treated with oral anticoagulants.<br />In single-dose pharmacokinetic (PK) studies in young healthy subjects, no relevant active substance active substance interaction of memantine with glyburide/metformin or donepezil was observed.<br />In a clinical study in young healthy subjects, no relevant effect of memantine on the pharmacokinetics of galantamine was observed.<br />Memantine did not inhibit CYP 1A2, 2A6, 2C9, 2D6, 2E1, 3A, flavin containing monooxygenase, epoxide hydrolase or sulphation in vitro.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pregnancy Category: B<br />There are no adequate and well-controlled studies of memantine in pregnant women. Memantine hydrochloride should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.<br />Breast-feeding<br />It is not known whether memantine is excreted in human breast milk but, taking into consideration the lipophilicity of the substance, this probably occurs. Women taking memantine should not breast-feed.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Moderate to severe Alzheimer&rsquo;s disease usually causes impairment of driving performance and compromises the ability to use machinery. Furthermore, MEXIA has minor to moderate influence on the ability to drive and use machines such that outpatients should be warned to take special care.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>In clinical trials in mild to severe dementia, involving 1,784 patients treated with memantine and 1,595 patients treated with placebo, the overall incidence rate of adverse reactions with memantine did not differ from those with placebo; the adverse reactions were usually mild to moderate in severity. The most frequently occurring adverse reactions with a higher incidence in the memantine group than in the placebo group were dizziness (6.3% vs 5.6%, respectively), headache (5.2% vs 3.9%), constipation (4.6% vs 2.6%), somnolence (3.4% vs 2.2%) and hypertension (4.1% vs 2.8%).</p><p>The following Adverse Drug Reactions listed in the Table below have been accumulated in clinical studies with memantine and since its introduction in the market. Within each frequency grouping, undesirable effects are presented in order of decreasing seriousness.<br />Adverse reactions are ranked according to system organ class, using the following convention: very common (&ge;1/10), common (&ge;1/100 to &lt;1/10), uncommon (&ge;1/1,000 to &lt;1/100), rare (&ge;1/10,000 to &lt;1/1,000), very rare (&lt;1/10,000), not known (cannot be estimated from the available data).<br />System organ class:<br />Frequency:<br />Undesirable effect:<br />Infections and infestations<br />Uncommon<br />Fungal infections<br />Immune system disorders<br />Common<br />Drug hypersensitivity<br />Psychiatric disorders<br />Common<br />Somnolence<br />Uncommon<br />Confusion<br />Hallucinations1<br />Not known<br />Psychotic reactions2<br />Nervous system disorders<br />Common<br />Dizziness<br />Balance disorders<br />Uncommon<br />Gait abnormal<br />Very rare<br />Seizures<br />Cardiac disorders<br />Uncommon<br />Cardiac failure<br />Vascular disorders<br />Common<br />Hypertension<br />Uncommon<br />Venous thrombosis/thromboembolism<br />Respiratory, thoracic and mediastinal disorders<br />Common<br />Dyspnoea<br />Gastrointestinal disorders<br />Common<br />Constipation<br />Uncommon<br />Vomiting<br />Not known<br />Pancreatitis2<br />General disorders and administration site conditions<br />Common<br />Headache<br />Uncommon<br />Fatigue<br />1 Hallucinations have mainly been observed in patients with severe Alzheimer&acute;s disease.<br />2 Isolated cases reported in post-marketing experience.<br />Alzheimer&rsquo;s disease has been associated with depression, suicidal ideation and suicide. In post-marketing experience these events have been reported in patients treated with memantine.</p><p>To reporting any side effect(s)<br />Saudi Arabia:<br />The National Pharmacovigilance and Drug Safety Centre (NPC)<br />Fax: +966-11-205-7662<br />Call NPC at +966-11-2038222, Exts: 2317-2356-2353-2354-2334-2340.<br />Toll free phone: 8002490000<br />E-mail: npc.drug@sfda.gov.sa<br />Website: www.sfda.gov.sa/npc<br />Other GCC States:<br />Please contact the relevant competent authority.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Only limited experience with overdose is available from clinical studies and post-marketing experience.<br />Symptoms:<br />Relative large overdoses (200 mg and 105 mg/day for 3 days, respectively) have been associated with either only symptoms of tiredness, weakness and/or diarrhoea or no symptoms. In the overdose cases below 140 mg or unknown dose the patients revealed symptoms from central nervous system (confusion, drowsiness, somnolence, vertigo, agitation, aggression, hallucination, and gait disturbance) and/or of gastrointestinal origin (vomiting and diarrhoea).<br />In the most extreme case of overdose, the patient survived the oral intake of a total of 2000 mg memantine with effects on the central nervous system (coma for 10 days, and later diplopia and agitation). The patient received symptomatic treatment and plasmapheresis. The patient recovered without permanent sequelae.<br />In another case of a large overdose, the patient also survived and recovered. The patient had received 400 mg memantine orally. The patient experienced central nervous system symptoms such as restlessness, psychosis, visual hallucinations, proconvulsiveness, somnolence, stupor, and unconsciousness.<br />Treatment:<br />In the event of overdose, treatment should be symptomatic. No specific antidote for intoxication or overdose is available. Standard clinical procedures to remove active substance material, e.g. gastric lavage, carbo medicinalis (interruption of potential entero-hepatic recirculation), acidification of urine, forced diuresis should be used as appropriate.<br />In case of signs and symptoms of general central nervous system (CNS) overstimulation, careful symptomatic clinical treatment should be considered.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic group: Other anti-dementia drugs, ATC code: N06DX01.<br />There is increasing evidence that malfunctioning of glutamatergic neurotransmission, in particular at NMDA-receptors, contributes to both expression of symptoms and disease progression in neurodegenerative dementia.<br />Memantine is a voltage-dependent, moderate-affinity uncompetitive NMDA-receptor antagonist. It modulates the effects of pathologically elevated tonic levels of glutamate that may lead to neuronal dysfunction.<br />Clinical studies<br />A pivotal monotherapy study in a population of patients suffering from moderate to severe Alzheimer&rsquo;s disease (mini mental state examination (MMSE) total scores at baseline of 3 - 14) included a total of 252 outpatients. The study showed beneficial effects of memantine treatment in comparison to placebo at 6 months (observed cases analysis for the clinician&acute;s interview based impression of change (CIBIC-plus): p=0.025; Alzheimer&acute;s disease cooperative study &ndash; activities of daily living (ADCS-ADLsev): p=0.003; severe impairment battery (SIB): p=0.002).<br />A pivotal monotherapy study of memantine in the treatment of mild to moderate Alzheimer&rsquo;s disease (MMSE total scores at baseline of 10 to 22) included 403 patients. Memantine-treated patients showed a statistically significantly better effect than placebo-treated patients on the primary endpoints: Alzheimer&acute;s disease assessment scale (ADAS-cog) (p=0.003) and CIBIC-plus (p=0.004) at week 24 (last observation carried forward (LOCF)). In another monotherapy study in mild to moderate Alzheimer&rsquo;s disease a total of 470 patients (MMSE total scores at baseline of 11-23) were randomised. In the prospectively defined primary analysis statistical significance was not reached at the primary efficacy endpoint at week 24.<br />A meta-analysis of patients with moderate to severe Alzheimer&rsquo;s disease (MMSE total scores &lt;20) from the six phase III, placebo-controlled, 6-month studies (including monotherapy studies and studies with patients on a stable dose of acetylcholinesterase inhibitors) showed that there was a statistically significant effect in favour of memantine treatment for the cognitive, global, and functional domains. When patients were identified with concurrent worsening in all three domains, results showed a statistically significant effect of memantine in preventing worsening, as twice as many placebo-treated patients as memantine-treated patients showed worsening in all three domains (21% vs. 11%, p&lt;0.0001).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Absorption:<br />Memantine has an absolute bioavailability of approximately 100%. Tmax is between 3 and 8 hours. There is no indication that food influences the absorption of memantine.<br />Distribution:</p><p>Daily doses of 20 mg lead to steady-state plasma concentrations of memantine ranging from 70 to 150 ng/ml (0.5 - 1 &mu;mol) with large interindividual variations. When daily doses of 5 to 30 mg were administered, a mean cerebrospinal fluid (CSF)/serum ratio of 0.52 was calculated. The volume of distribution is around 10 l/kg. About 45% of memantine is bound to plasma-proteins.<br />Biotransformation:<br />In man, about 80% of the circulating memantine-related material is present as the parent compound. Main human metabolites are N-3,5-dimethyl-gludantan, the isomeric mixture of 4- and 6-hydroxy-memantine, and 1-nitroso-3,5-dimethyl-adamantane. None of these metabolites exhibit NMDA-antagonistic activity. No cytochrome P 450 catalysed metabolism has been detected in vitro.<br />In a study using orally administered 14C-memantine, a mean of 84% of the dose was recovered within 20 days, more than 99% being excreted renally.<br />Elimination:<br />Memantine is eliminated in a monoexponential manner with a terminal t1/2 of 60 to 100 hours. In volunteers with normal kidney function, total clearance (Cltot) amounts to 170 ml/min/1.73 m&sup2; and part of total renal clearance is achieved by tubular secretion.<br />Renal handling also involves tubular reabsorption, probably mediated by cation transport proteins. The renal elimination rate of memantine under alkaline urine conditions may be reduced by a factor of 7 to 9 (see section 4.4). Alkalisation of urine may result from drastic changes in diet, e.g. from a carnivore to a vegetarian diet, or from the massive ingestion of alkalising gastric buffers.<br />Linearity:<br />Studies in volunteers have demonstrated linear pharmacokinetics in the dose range of 10 to 40 mg.<br />Pharmacokinetic/pharmacodynamic relationship:<br />At a dose of memantine of 20 mg per day the CSF levels match the ki-value (ki = inhibition constant) of memantine, which is 0.5 &mu;mol in human frontal cortex.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>In short term studies in rats, memantine like other NMDA-antagonists have induced neuronal vacuolisation and necrosis (Olney lesions) only after doses leading to very high peak serum concentrations. Ataxia and other preclinical signs have preceded the vacuolisation and necrosis. As the effects have neither been observed in long term studies in rodents nor in non-rodents, the clinical relevance of these findings is unknown.<br />Ocular changes were inconsistently observed in repeat dose toxicity studies in rodents and dogs, but not in monkeys. Specific ophthalmoscopic examinations in clinical studies with memantine did not disclose any ocular changes.<br />Phospholipidosis in pulmonary macrophages due to accumulation of memantine in lysosomes was observed in rodents. This effect is known from other active substances with cationic amphiphilic properties. There is a possible relationship between this accumulation&nbsp;and the vacuolisation observed in lungs. This effect was only observed at high doses in rodents. The clinical relevance of these findings is unknown.<br />No genotoxicity has been observed following testing of memantine in standard assays. There was no evidence of any carcinogenicity in life long studies in mice and rats. Memantine was not teratogenic in rats and rabbits, even at maternally toxic doses, and no adverse effects of memantine were noted on fertility. In rats, foetal growth reduction was noted at exposure levels, which are identical or slightly higher than at human exposure.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Lactose DC (Ludipress LCE: Lactose monohydrate + Povidone 30)<br />Microcrystalline cellulose PH 302 (Avicel PH 302)<br />Colloidal silica anhydrous (Aerosil 200)<br />Talc<br />Magnesium stearate<br />Film coating material no:8 (Opadry Y-1 7000 White) :<br />HPMC 2910/Hypromellose 5 cp (E464)<br />Titanium Dioxide (E171)<br />Macrogol / PEG 400 (E1521)</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not applicable.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                2 years.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Keep out of the sight and reach of children.<br />Store below 30&ordm;C, in its own pack.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Blister of transparent PVC/PE/PVDC/AL foil<br />28 film-coated tablets / 2 blisters / 1 box ( 14 film-coated tablets / 1 blister)</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No special requirements for disposal.</p><p>Any unused medicinal product or waste material should be disposed of in accordance with local requirements</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                NOBEL İLAÇ SAN. VE TİC. A.Ş.
İnkılap Mahallesi Akçakoca Sokak No: 10
34768 Ümraniye / İSTANBUL / TÜRKİYE
Tel: +90 (216) 633 60 00
Fax: +90 (216) 633 60 01
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                26.10.2015
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>